Cargando…
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care
Genomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for adv...
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902467/ https://www.ncbi.nlm.nih.gov/pubmed/36599918 http://dx.doi.org/10.1038/s41416-022-02107-8 |
| _version_ | 1784883268048388096 |
|---|---|
| author | Cerone, Maria Antonietta Mills, Tara C. Sharpe, Rowena McBride, David MacDonald, Moira MacMahon, Suzanne Mugalaasi, Hood Rehal, Pauline Rettino, Alessandro Roberts, Helen Ross, Mark White, Donald Edward Peden, John Rawlinson, Janette Ho, Steffan N. Hollingsworth, Simon Popat, Sanjay Middleton, Gary Johnson, Peter Swanton, Charles |
| author_facet | Cerone, Maria Antonietta Mills, Tara C. Sharpe, Rowena McBride, David MacDonald, Moira MacMahon, Suzanne Mugalaasi, Hood Rehal, Pauline Rettino, Alessandro Roberts, Helen Ross, Mark White, Donald Edward Peden, John Rawlinson, Janette Ho, Steffan N. Hollingsworth, Simon Popat, Sanjay Middleton, Gary Johnson, Peter Swanton, Charles |
| author_sort | Cerone, Maria Antonietta |
| collection | PubMed |
| description | Genomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for advanced NSCLC patients, which could be useful to better plan future studies. |
| format | Online Article Text |
| id | pubmed-9902467 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99024672023-02-08 The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care Cerone, Maria Antonietta Mills, Tara C. Sharpe, Rowena McBride, David MacDonald, Moira MacMahon, Suzanne Mugalaasi, Hood Rehal, Pauline Rettino, Alessandro Roberts, Helen Ross, Mark White, Donald Edward Peden, John Rawlinson, Janette Ho, Steffan N. Hollingsworth, Simon Popat, Sanjay Middleton, Gary Johnson, Peter Swanton, Charles Br J Cancer Comment Genomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for advanced NSCLC patients, which could be useful to better plan future studies. Nature Publishing Group UK 2023-01-04 2023-01-19 /pmc/articles/PMC9902467/ /pubmed/36599918 http://dx.doi.org/10.1038/s41416-022-02107-8 Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Comment Cerone, Maria Antonietta Mills, Tara C. Sharpe, Rowena McBride, David MacDonald, Moira MacMahon, Suzanne Mugalaasi, Hood Rehal, Pauline Rettino, Alessandro Roberts, Helen Ross, Mark White, Donald Edward Peden, John Rawlinson, Janette Ho, Steffan N. Hollingsworth, Simon Popat, Sanjay Middleton, Gary Johnson, Peter Swanton, Charles The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care |
| title | The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care |
| title_full | The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care |
| title_fullStr | The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care |
| title_full_unstemmed | The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care |
| title_short | The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care |
| title_sort | cancer research uk stratified medicine programme as a model for delivering personalised cancer care |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902467/ https://www.ncbi.nlm.nih.gov/pubmed/36599918 http://dx.doi.org/10.1038/s41416-022-02107-8 |
| work_keys_str_mv | AT ceronemariaantonietta thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT millstarac thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT sharperowena thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT mcbridedavid thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT macdonaldmoira thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT macmahonsuzanne thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT mugalaasihood thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT rehalpauline thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT rettinoalessandro thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT robertshelen thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT rossmark thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT whitedonaldedward thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT pedenjohn thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT rawlinsonjanette thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT hosteffann thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT hollingsworthsimon thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT popatsanjay thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT middletongary thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT johnsonpeter thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT swantoncharles thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT thecancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT ceronemariaantonietta cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT millstarac cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT sharperowena cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT mcbridedavid cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT macdonaldmoira cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT macmahonsuzanne cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT mugalaasihood cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT rehalpauline cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT rettinoalessandro cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT robertshelen cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT rossmark cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT whitedonaldedward cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT pedenjohn cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT rawlinsonjanette cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT hosteffann cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT hollingsworthsimon cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT popatsanjay cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT middletongary cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT johnsonpeter cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT swantoncharles cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare AT cancerresearchukstratifiedmedicineprogrammeasamodelfordeliveringpersonalisedcancercare |